Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
12/2008
12/02/2008US7459473 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth
12/02/2008US7459469 N-methyl-5-(5-isopropoxy-3-pyridinyl)-4-penten-2-amine p-hydroxybenzoate; compounds can activate nicotinic receptor and can modulate neurotransmitter secretion; neuroprotective agents; side effects reduction; pains; easy to remove impurities; heck coupling reaction; CNS disorders; inflammatory disorders
12/02/2008US7459467 selective and complete reduction of pyridine ring in a biaryl system comprising proportional-variant -substituted or non-substituted benzene ring; Attention Deficit Hyperactive Disorder (ADHD) and central nervous system stimulant
12/02/2008US7459414 Herbicides
12/02/2008CA2516108C Polymorphs of donepezil hydrochloride and process for production
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2337032C Derivatives of 1-oxyl-4-hydroxy- or 4-amino-2,2,6,6-tetramethylpiperidine as polymerization inhibitors for (meth)acrylate monomers
12/02/2008CA2317444C N-acyl cyclic amine derivatives
12/02/2008CA2272973C Method for inhibiting polymer formation in styrene processing
12/02/2008CA2186380C Novel carbamates and ureas as modifiers of multi-drug resistance
11/2008
11/27/2008WO2008144773A1 New method for preparing isofagomine and its derivatives
11/27/2008WO2008144326A2 Synthesis of n-(4-fluorobenzyl)-n-(l-methylpiperidin-4-yl)-n'-(4- (2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
11/27/2008WO2008142285A1 Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
11/27/2008WO2008142155A2 Method for preparing c-6 phosphorylated d-aldohexoses and c-6 phosphorylated d-aldohexoses derivatives and new c-6 phosphorylated d-aldohexoses derivatives
11/27/2008WO2008141462A1 Novel case of renin inhibitors
11/27/2008WO2008085765A3 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
11/27/2008WO2008070697A3 Stat3 inhibitor having anti-cancer activity and associated methods
11/27/2008WO2008036168A3 New small molecule inhibitors of mdm2 and the uses thereof
11/27/2008WO2007140184A3 Deoxynojirimycin and d-arabinitol analogs and methods of using
11/27/2008WO2007136790A3 Intracellular kinase inhibitors
11/27/2008WO2007106508A3 Use of tetrahydropyridines in the treatment of central nervous system disorders
11/27/2008WO2007098086A3 Hydroxypiperidine derivatives and uses thereof
11/27/2008WO2005025498A3 Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
11/27/2008US20080293948 Process for the preparation of keto compounds
11/27/2008US20080293754 Cyclopamine analogs
11/27/2008US20080293753 Novel Compounds
11/27/2008US20080293722 Ion Channel Modulators
11/27/2008US20080293701 1-Acylamino-2-Hydroxy-3-Amino- -Arylalkanes as Renin Inhibitors
11/27/2008US20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
11/27/2008DE19607203B4 Thermoplastische Harzmasse A thermoplastic resin composition
11/27/2008CA2692001A1 Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
11/27/2008CA2688850A1 New method for preparing isofagomine and its derivatives
11/27/2008CA2688057A1 Novel case of renin inhibitors
11/27/2008CA2683350A1 Nitrogenous heterocyclic compounds, preparation thereof and use thereof a antibacterial medicaments
11/26/2008EP1995323A1 Method for preparing C-6 phosphorylated D-aldohexoses and C-6 phosphorylated D-aldohexose derivatives
11/26/2008EP1994003A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them .
11/26/2008EP1994002A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
11/26/2008EP1994001A2 Benzeneszkfibate salts and their use as intermediates for the synthesis of 2-[2-(1-alkyl-2-piperidyl)ethyl] cinnamanilides
11/26/2008EP1811957B1 Solid pharmaceutical composition comprising donepezil hydrochloride
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008CN101312949A Process for synthesizing remifentanil
11/26/2008CN101312948A Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
11/26/2008CN101311165A Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
11/26/2008CN101310771A Visual function disorder improving agents
11/26/2008CN100436447C Compounds possessing neuronal activity
11/26/2008CN100436425C Fused imidazolium derivatives
11/26/2008CN100436417C Resolution method of optically active amlodipine
11/26/2008CN100436416C Novel donepezil synthesis process
11/26/2008CN100436415C Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
11/25/2008US7456292 Hydroxamic acid-containing amino acid derivatives
11/25/2008US7456291 Use of a vitamin combination for the treatment of primary headaches
11/25/2008US7456290 Process for the preparation of 2-aminomethylpyridine derivative
11/25/2008US7456203 for treatment/prevention of chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, and urinary incontinence
11/25/2008US7456199 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-(4-[(4-hydroxybenzylamino)methyl]phenylcarbamoyl)ethyl)piperidin-4-yl ester
11/25/2008US7456198 Useful in the treatment of chronic and acute pain.
11/25/2008US7456153 Comprise at least a tryptophan-containing cell adhesion recognition sequence; cancer modulating agent
11/25/2008CA2362211C Benzamide derivatives and medicament containing the same
11/20/2008WO2008141057A1 Deuterated pimavanserin 1- (4-flu0r0benzyl) -3- (4-isobutoxybenzyl) -1- ( l-methyl-piperidin-4-yl) -urea
11/20/2008WO2008140198A1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008WO2008138946A1 Bisamide-zinc bases
11/20/2008WO2008138918A1 Mono-hydrochloric salts of an inhibitor of histone deacetylase
11/20/2008WO2008138639A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
11/20/2008US20080287674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade
11/20/2008US20080287500 Diastereomers of 4-aryloxy-3-hydroxypiperidines
11/20/2008US20080287499 N-deacetylthiocolchicine deriatives, their use and pharmaceutical formulations containing them
11/20/2008US20080287441 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
11/20/2008US20080287407 Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
11/20/2008US20080286843 Process for Preparing 2-Hydroxy-Substituted Pyridines
11/20/2008US20080286204 Including cystic fibrosis transmembrane conductance regulator ("CFTR"); N[6-(2-hydroxymethylphenyl-1yl)-5-methylpyrimidine][(4-methoxophenyl-1-yl)cyclopopyl]-amide; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema and hemochromatosis, coagulation-fibrinolysis
11/20/2008DE102007022490A1 Bisamid-Zinkbasen Bisamide-zinc base
11/20/2008CA2686926A1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008CA2686484A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
11/20/2008CA2683195A1 Mono-hydrochloric salts of an inhibitor of histone deacetylase
11/19/2008EP1992616A1 Process for the preparation of donepezil and intermediate compounds thereof as well as hydrates of donepezil
11/19/2008EP1992615A1 A process for the preparation of keto compounds
11/19/2008EP1991528A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
11/19/2008EP1991233A2 Hydroxypiperidine derivatives and uses thereof
11/19/2008EP1434764B1 Process for obtainment of enantiomers-of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; process for obtainment of non-racemic mixtures between the enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; non racemic mixtures of enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide;pharmaceuticals compositions comprising said non-racemic mixtures of enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide
11/19/2008CN101309916A Process for production of cinnamamide derivative
11/19/2008CN101309891A Process for preparing beta- (fluorophenyl) -propanoate ester derivatives
11/19/2008CN101307020A Amlodipine-zinc sulfate salts, preparing process thereof and application thereof
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/18/2008US7452997 Tetrahydro-indazole cannabinoid modulators
11/18/2008US7452908 Amide derivatives
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008US7452891 MCH antagonists and their use in the treatment of obesity
11/18/2008US7452889 e.g. 3-(2-methylbenzothiazol-5-yloxy)-1-[4-(3-phenoxypropyl)piperazinyl]propan-2-ol; fatty acid oxidation inhibitor; cardiovascular diseases: atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's angina, stable and unstable angina, and diabetes
11/18/2008US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/16/2008CA2631376A1 A process for the preparation of keto compounds
11/13/2008WO2008113360A3 4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression
11/13/2008US20080280952 Pyridine Derivatives as Connabinoid Receptor Modulators
11/13/2008US20080280951 Salt Il
11/13/2008US20080280925 Amines as Small Molecule Inhibitors
11/12/2008EP1989183A1 Crystalline form of remifentanil hydrochloride
11/12/2008EP1606282B1 Phenyl- and pyridylpipereidinye-derivatives as modulators of glucose metabolism
11/12/2008CN101304969A Benzene derivative or salt thereof
11/12/2008CN101304743A Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
11/12/2008CN101302549A High-purity miglitol production process
11/12/2008CN101302172A 3,5-diiodosalicylaldehyde Schiff alkali, preparation and use thereof
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 380